Peng Yang

10.1k total citations · 1 hit paper
184 papers, 4.1k citations indexed

About

Peng Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peng Yang has authored 184 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 32 papers in Oncology and 31 papers in Immunology. Recurrent topics in Peng Yang's work include Aquaculture Nutrition and Growth (16 papers), Aquaculture disease management and microbiota (11 papers) and Cancer-related molecular mechanisms research (11 papers). Peng Yang is often cited by papers focused on Aquaculture Nutrition and Growth (16 papers), Aquaculture disease management and microbiota (11 papers) and Cancer-related molecular mechanisms research (11 papers). Peng Yang collaborates with scholars based in China, United States and Poland. Peng Yang's co-authors include Xiaoqing Hu, Yingfang Ao, Xiang‐Qun Xie, Jin Cheng, Wenjian Min, Xiao Wang, Hui‐Lei Yu, Zhiwei Feng, Danqing Song and Xiaoning Duan and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peng Yang

172 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells

2020 163 citations Peng Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Yang China	34	1.6k	747	703	595	457	184	4.1k
Jing Wei China	30	1.5k 0.9×	449 0.6×	1.3k 1.8×	417 0.7×	176 0.4×	140	4.5k
Dongming Xing China	43	3.3k 2.1×	760 1.0×	844 1.2×	458 0.8×	370 0.8×	220	6.7k
Jae‐Sung Kim South Korea	36	2.1k 1.3×	737 1.0×	229 0.3×	248 0.4×	261 0.6×	124	4.3k
Jian Luo China	48	3.9k 2.4×	1.0k 1.4×	476 0.7×	391 0.7×	243 0.5×	133	6.3k
Wei‐Chien Huang Taiwan	44	3.2k 1.9×	1.3k 1.8×	325 0.5×	644 1.1×	481 1.1×	123	5.8k
Ke Xu China	38	2.1k 1.3×	792 1.1×	183 0.3×	444 0.7×	307 0.7×	145	4.2k
Chiara Dianzani Italy	42	2.0k 1.3×	434 0.6×	211 0.3×	694 1.2×	220 0.5×	124	4.8k
Yukio Fujiwara Japan	40	1.9k 1.2×	1.1k 1.5×	250 0.4×	1.6k 2.8×	466 1.0×	205	5.3k
Min Zhang China	32	1.5k 0.9×	578 0.8×	192 0.3×	323 0.5×	261 0.6×	209	4.1k
Karin Müller‐Decker Germany	38	2.0k 1.2×	654 0.9×	912 1.3×	537 0.9×	259 0.6×	87	4.6k

Countries citing papers authored by Peng Yang

Since Specialization

Citations

This map shows the geographic impact of Peng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yang more than expected).

Fields of papers citing papers by Peng Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yang. The network helps show where Peng Yang may publish in the future.

Co-authorship network of co-authors of Peng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Yang. A scholar is included among the top collaborators of Peng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Yang. Peng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yuntao, Peng Yang, Shan Gao, et al.. (2025). Comparative analysis of the non-volatile flavor of mud crab (Scylla paramamosain) cultured in sea water and coastal low saline-alkali water. Journal of Food Composition and Analysis. 142. 107530–107530. 1 indexed citations

Wang, Dawei, Wenjian Min, Baichuan Jiang, et al.. (2025). From concept to application: Exploring the evolution and potential of DUBTAC technology. Acta Pharmaceutica Sinica B. 16(2). 770–787.

Min, Wenjian, Yi Hou, Dawei Wang, et al.. (2025). Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein–Protein Interaction. Journal of Medicinal Chemistry. 68(2). 1844–1862. 6 indexed citations

Hou, Yi, Qin Han, Xiao Zheng, et al.. (2025). Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy. Journal of Medicinal Chemistry. 68(22). 24404–24423.

Li, Jiaxing, Chengliang Sun, Ying Zhang, et al.. (2025). Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 68(8). 8244–8268.

Li, Yuntao, Shan Gao, Peng Yang, et al.. (2024). Effects of aquatic Ca2+ and Mg2+ on the antioxidant, immune, osmotic regulation, molting, and metabolic abilities of Scylla paramamosain. Aquaculture. 596. 741875–741875. 1 indexed citations

Shen, Hao, et al.. (2024). Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types. 3(2). 37–48. 2 indexed citations

Zhang, Jiaojiao, Jia Li, Jian Ma, et al.. (2024). Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season. Vaccine. 46. 126662–126662. 2 indexed citations

Wang, Kaili, Yanyan Wang, Tingting Zhang, et al.. (2024). Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis. Frontiers in Pharmacology. 15. 1426767–1426767.

10.

Sun, Chengliang, Yao Cheng, Jingwen Dong, et al.. (2024). Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents. Journal of Medicinal Chemistry. 68(1). 156–173. 3 indexed citations

11.

Sun, Chengliang, Yuling He, Gefei Wang, et al.. (2024). Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors. Journal of Medicinal Chemistry. 67(5). 3590–3605. 13 indexed citations

12.

Gui, Yuan, Haiyan Fu, Jianling Tao, et al.. (2024). Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injury. Journal of Clinical Investigation. 134(13). 7 indexed citations

13.

Min, Wenjian, Hongtao Shen, Tong Chen, et al.. (2023). Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment. European Journal of Medicinal Chemistry. 264. 116025–116025. 5 indexed citations

14.

Hou, Yi, Fang Zhang, Wenjian Min, et al.. (2022). Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. Journal of Medicinal Chemistry. 65(14). 9873–9892. 12 indexed citations

15.

Wang, Xiao, et al.. (2022). Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Cancers. 14(15). 3629–3629. 5 indexed citations

16.

Yang, Yang, Peng Yang, Yuming Wu, et al.. (2021). Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca²⁺‐dependent membrane fusion. Journal of Medical Virology. 93(10). 5825–5832. 21 indexed citations

17.

Ge, Haixia, et al.. (2021). Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia. European Journal of Medicinal Chemistry. 221. 113522–113522. 6 indexed citations

18.

Yuan, Kai, et al.. (2020). Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs. Acta Pharmaceutica Sinica B. 11(1). 30–54. 103 indexed citations

19.

Wang, Ke Yu, Rui Chen, Linlin Liu, et al.. (2017). Characterization of Highly Pathogenic Avian Influenza H5N1 Viruses Isolated from Domestic Poultry in China.. PubMed. 30(1). 68–74. 1 indexed citations

20.

Yang, Peng, et al.. (2016). Long noncoding RNA expression profile analysis of colorectal cancer and metastatic lymph node based on microarray data. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact